E1	Condition:T1 Name:T2
E3	Condition:T3 Name:T4
E5	Condition:T5 Name:T6 Minimum-Count:E39
E9	Procedure:T9 Name:T10
E11	Condition:T11 Name:T12
E15	Procedure:T15 Name:T16
E16	Eq-Comparison:T30 Temporal-Period:T31
E17	Eq-Comparison:T32 Temporal-Period:T33
E18	Eq-Comparison:T34 Temporal-Period:T35
E19	Eq-Comparison:T36 Temporal-Period:T37
E20	Eq-Comparison:T38 Operator:T19 Value:T39 Temporal-Unit:T21
E2	Condition:T22 Name:T40
E4	Modifier:T41 Modifies:T40
E6	Condition:T42 Name:T43
E8	Condition:T44 Name:T45
E10	Procedure:T46 Name:T47
E12	And:T48 Arg:E6 Arg2:E10
E14	Condition:T49 Name:T50
E21	Modifier:T51 Modifies:T50
E22	Modifier:T52 Modifies:T50
E23	Or:T53 Arg:E21 Arg2:E22
E24	Condition:T54 Name:T55
E25	Condition:T23 Name:T56
E26	Condition:T57 Name:T58
E27	Modifier:T59 Modifies:T58
E28	Procedure:T60 Name:T61
E29	Or:T62 Arg:E25 Arg2:E26
E30	Condition:T63 Name:T64
E31	Modifier:T24 Modifies:T2
E32	Modifier:T65 Modifies:T2
E33	Or:T66 Arg:E32 Arg2:E31
E34	Modifier:T25 Modifies:T4
E35	Modifier:T67 Modifies:T4
E36	Or:T68 Arg:E35 Arg2:E34
E37	Condition:T69 Name:T70
E38	Modifier:T71 Modifies:T70
E39	Eq-Comparison:T26 Operator:T72 Value:T73
E7	Procedure:T7 Name:T8 Temporality:E17
E40	Procedure:T74
E41	Assertion:T75 Asserted:E40
E42	Condition:T27 Name:T76
E43	Procedure:T77 Name:T78
E44	Modifier:T79 Modifies:T78
E45	Assertion:T80 Asserted:E43
E46	Procedure:T81 Name:T82
E47	Risk:T83
E48	Exception:T84 From:E43 Except:E46
E49	Eq-Comparison:T85 Operator:T86 Temporal-Unit:T20 Value:T28
E50	Procedure:T87 Name:T88 Temporality:E18
E51	Study:T89 Study-Of:E52
E52	Drug:T90 Name:T91 Temporality:E53 Temporality2:E49
E53	Eq-Comparison:T92 Temporal-Recency:T93
E54	Temporal-Connection:T94 Arg:E50 Arg2:E49
E55	Observation:T17 Name:T95 Eq-Comparison:E56
E56	Eq-Comparison:T96 Unit:T97 Operator:T98 Operator2:T18 Value:T29
E57	Study:T99
E58	Or:T100 Arg:E56 Arg2:E57
E59	Procedure:T101 Temporality:E19
E60	Drug:T102 Name:T103
E61	Drug:T104 Name:T105
E13	Immunization:T13 Name:T14
E62	Exception:T106 From:E61 Except:E13
E63	Modifier:T107 Modifies:T10
E64	Modifier:T108 Modifies:T10
E65	Or:T109 Arg:E64 Arg2:E63
E66	Condition:T110
E67	Condition:T111 Name:T112
E68	Or:T113 Arg:E67 Arg2:E66
E69	Condition:T114 Name:T115
E70	Condition:T116 Name:T117
E71	Or:T118 Arg:E69 Arg2:E70
E72	Assertion:T119 Asserted:E69 Asserted2:E70
E73	Condition:T120 Name:T121 Temporality:E16
E74	Other:T122 Is-Other:E73
E75	Procedure:T123 Temporality:E20
E76	Modifier:T124 Modifies:E75
E77	Assertion:T125 Asserted:E75
E78	Study:T126
E79	Temporal-Connection:T127 Arg:E20 Arg2:E78
T1	Condition 520 492	disease
T2	Condition-Name 520 492	disease
T3	Condition 571 540	disease
T4	Condition-Name 571 540	disease
T5	Condition 635 600	lesion
T6	Condition-Name 635 600	lesion
T9	Procedure 1431 1363	transplantation
T10	Procedure-Name 1431 1363	transplantation
T11	Condition 694 657	disease progression
T12	Condition-Name 694 657	disease progression
T15	Procedure 1104 1054	radiotherapy
T16	Procedure-Name 1104 1054	radiotherapy
T18	Eq-Operator 1225 1169	<=
T19	Eq-Operator 1580 1510	<=
T20	Eq-Temporal-Unit 1044 995	weeks
T21	Eq-Temporal-Unit 1591 1519	months
T28	Eq-Value 1038 989	2
T29	Eq-Value 1231 1172	1
T30	Eq-Comparison 1535 1467	active
T31	Eq-Temporal-Period 1535 1467	active
T32	Eq-Comparison 703 666	prior
T33	Eq-Temporal-Period 703 666	prior
T34	Eq-Comparison 1058 1009	prior
T35	Eq-Temporal-Period 1058 1009	prior
T36	Eq-Comparison 1254 1195	Prior
T37	Eq-Temporal-Period 1254 1195	Prior
T38	Eq-Comparison 1591 1519	<=12 months
T22	Condition 98 91	cancer
T40	Condition-Name 98 91	cancer
T41	Modifier 91 84	Metastatic castration-resistant prostate
T42	Condition 106 98	mCRPC
T43	Condition-Name 106 98	mCRPC
T44	Condition 155 146	adenocarcinoma
T45	Condition-Name 155 146	adenocarcinoma
T46	Procedure 124 115	histologic
T47	Procedure-Name 124 115	histologic
T48	And 113 104	with
T49	Condition 173 162	Adenocarcinoma
T50	Condition-Name 173 162	Adenocarcinoma
T51	Modifier 191 178	small-cell
T52	Modifier 209 196	neuroendocrine
T53	Or 194 181	or
T54	Condition 238 223	mCRPC
T55	Condition-Name 238 223	mCRPC
T23	Condition 322 300	mCRPC
T56	Condition-Name 322 300	mCRPC
T57	Condition 399 377	carcinoma
T58	Condition-Name 399 377	carcinoma
T59	Modifier 389 367	metastatic renal cell
T60	Procedure 357 335	pathologically
T61	Procedure-Name 357 335	pathologically
T62	Or 342 320	or
T63	Condition 405 382	RCC
T64	Condition-Name 405 382	RCC
T24	Modifier 512 484	evaluable
T65	Modifier 499 471	Measurable
T66	Or 502 474	or
T25	Modifier 563 532	evaluable
T67	Modifier 550 519	measurable
T68	Or 553 522	or
T69	Condition 591 560	cancer
T70	Condition-Name 591 560	cancer
T71	Modifier 584 553	prostate
T26	Eq-Comparison 617 582	At least one
T72	Eq-Operator 613 578	At least
T73	Eq-Value 617 582	one
T7	Procedure 711 674	therapy
T8	Procedure-Name 711 674	therapy
T74	Procedure 749 712	treatment
T75	Assertion 725 688	requires
T27	Condition 791 754	lesions
T76	Condition-Name 791 754	lesions
T77	Procedure 942 897	biopsies
T78	Procedure-Name 942 897	biopsies
T79	Modifier 933 888	fresh tumor
T80	Assertion 899 854	agree to
T81	Procedure 976 930	biopsy
T82	Procedure-Name 976 930	biopsy
T83	Risk 999 953	risk
T84	Exception 951 905	unless
T85	Eq-Comparison 1044 995	At least 2 weeks
T86	Eq-Operator 1035 987	At least
T87	Procedure 1079 1030	anticancer treatment
T88	Procedure-Name 1079 1030	anticancer treatment
T89	Study 1150 1099	study
T90	Drug 1155 1104	drug
T91	Drug-Name 1155 1104	drug
T92	Eq-Comparison 1136 1085	first
T93	Eq-Temporal-Recency 1136 1085	first
T94	Temporal-Connection 1052 1003	between
T17	Observation 1172 1120	toxicities
T95	Observation-Name 1172 1120	toxicities
T96	Eq-Comparison 1231 1172	Grade less than or equal to (<=) 1
T97	Eq-Unit 1195 1143	Grade
T98	Eq-Operator 1214 1162	less than or equal
T99	Study 1243 1184	baseline
T100	Or 1234 1175	or
T101	Procedure 1264 1205	treatment
T102	Drug 1306 1245	prostate-specific membrane antigen
T103	Drug-Name 1306 1245	prostate-specific membrane antigen
T104	Drug 1313 1251	PSMA
T105	Drug-Name 1313 1251	PSMA
T13	Immunization 1370 1302	PSMA-targeted vaccine
T14	Immunization-Name 1370 1302	PSMA-targeted vaccine
T106	Exception 1342 1276	except
T107	Modifier 1415 1347	bone marrow
T108	Modifier 1400 1332	Solid organ
T109	Or 1403 1335	or
T110	Condition 1463 1395	condition
T111	Condition 1444 1376	Seizure
T112	Condition-Name 1444 1376	Seizure
T113	Or 1447 1379	or
T114	Condition 1494 1426	seizure
T115	Condition-Name 1494 1426	seizure
T116	Condition 1517 1449	intracranial masses
T117	Condition-Name 1517 1449	intracranial masses
T118	Or 1497 1429	or
T119	Assertion 1472 1404	may
T120	Condition 1546 1478	malignancy
T121	Condition-Name 1546 1478	malignancy
T122	Other 1528 1460	Other
T123	Procedure 1575 1507	treatment
T124	Modifier 1565 1497	systemic
T125	Assertion 1556 1488	requiring
T39	Eq-Value 1584 1512	12
T126	Study 1611 1539	enrollment
T127	Temporal-Connection 1600 1528	prior to
A2	Eq-Operator-Value T18 LTEQ
A3	Eq-Operator-Value T19 LTEQ
A4	Eq-Temporal-Unit-Value T20 week
A5	Eq-Temporal-Unit-Value T21 month
A6	Eq-Temporal-Period-Value T31 present
A7	Eq-Temporal-Period-Value T33 past
A8	Eq-Temporal-Period-Value T35 past
A9	Eq-Temporal-Period-Value T37 past
A11	Eq-Operator-Value T72 GTEQ
A12	Assertion-Type-Value E41 hypothetical
A13	Assertion-Type-Value E45 hypothetical
A14	Eq-Operator-Value T86 GTEQ
A15	Eq-Temporal-Recency-Value T93 first-time
A16	Temporal-Connection-Type-Value E54 after
A1	Eq-Operator-Value T98 LTEQ
A17	Assertion-Type-Value E72 hypothetical
A18	Assertion-Type-Value E77 hypothetical
A10	Temporal-Connection-Type-Value E79 before
R1	Abbrev-Of Arg1:E6 Arg2:E2
R2	Found-By Arg1:E8 Arg2:E10
R3	Found-By Arg1:E26 Arg2:E28
R4	Abbrev-Of Arg1:E30 Arg2:E26
R5	Example-Of Arg1:E37 Arg2:E3
R6	Found-By Arg1:E11 Arg2:E7
R7	Treatment-For Arg1:E40 Arg2:E11
R8	Caused-By Arg1:E47 Arg2:E46
R9	Example-Of Arg1:E15 Arg2:E50
R10	Using Arg1:E59 Arg2:E60
R11	Abbrev-Of Arg1:E61 Arg2:E60
R12	Caused-By Arg1:E69 Arg2:E66
R13	Treatment-For Arg1:E75 Arg2:E73